A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2011
12/01/2011	US20110294845 Parenteral formulations
12/01/2011	US20110294839 Novel polymorphs of lopinavir
12/01/2011	US20110294828 Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
12/01/2011	US20110294826 Pyrrolo[2,3-d]pyrimidine compounds
12/01/2011	US20110294819 Hepatitis C Virus Inhibitors
12/01/2011	US20110294809 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
12/01/2011	US20110294805 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators and methods of use thereof
12/01/2011	US20110294802 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2011	US20110294801 Macrocyclics pyrimidines as aurora kinase inhibitors
12/01/2011	US20110294795 Methods of synthesis and/or purification of diaminophenothiazinium compounds
12/01/2011	US20110294785 Influenza a virus inhibition
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294778 Hepatitis c inhibitor compounds
12/01/2011	US20110294777 Beta-lactamase inhibitors
12/01/2011	US20110294774 Identification and application of antibiotic synergy
12/01/2011	US20110294772 Use of cyclosquaramide compounds as anti-tumour agents
12/01/2011	US20110294768 Ophthalmic Suspension for Ocular Use
12/01/2011	US20110294765 Procedure for obtaining an aqueous dispersion of alcohols and acids from jojoba oil, processes for obtaining self-emulsified jojoba oil, aqueous dispersions and emulsions of jojoba oil in the same and pharmaceutical or cosmetic compositions comprising the same
12/01/2011	US20110294760 Compositions and Methods for Preventing Sternal Wound Infections
12/01/2011	US20110294752 Triterpene compositions and methods for use thereof
12/01/2011	US20110294746 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
12/01/2011	US20110294728 Antiviral Polypeptides
12/01/2011	US20110294727 Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
12/01/2011	US20110294726 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
12/01/2011	US20110294724 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
12/01/2011	US20110294723 Compounds
12/01/2011	US20110294722 Antimicrobial peptides
12/01/2011	US20110294721 Antimicrobial peptides
12/01/2011	US20110294665 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110293756 Preventives or remedies for tumor or human papillomaviral disease
12/01/2011	US20110293753 Tocotrienol Compositions
12/01/2011	US20110293733 Self-assembling nanoparticle drug delivery system
12/01/2011	US20110293730 Polylactide nanoparticles
12/01/2011	US20110293727 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293723 Synthetic nanocarrier combination vaccines
12/01/2011	US20110293717 Compacted moxifloxacin
12/01/2011	US20110293715 Pharmaceutical Formulation and Process for Its Preparation
12/01/2011	US20110293705 Methods and compositions for localized agent delivery
12/01/2011	US20110293701 Multivalent synthetic nanocarrier vaccines
12/01/2011	US20110293700 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	US20110293699 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293697 HIV-1 Immunogenic Compositions
12/01/2011	US20110293688 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293686 Anti-viral compositions and methods for administration
12/01/2011	US20110293681 Hand sanitizing patch having an integrally bonded antimicrobial
12/01/2011	US20110293671 Bacteriophage compositions for treatment of bacterial infections
12/01/2011	US20110293662 Compositions comprising reduced genome bacteria for use in treatment of sepsis
12/01/2011	US20110293660 Novel method
12/01/2011	US20110293659 Method for the oral/mucosal vaccination by means of recombinant yeasts
12/01/2011	US20110293658 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
12/01/2011	US20110293657 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
12/01/2011	US20110293656 Recombinant mva capable of expressing structural hcv antigens
12/01/2011	US20110293655 Porcine Adenovirus 3-Based PRRSV Vaccines
12/01/2011	US20110293652 Chimeric ospa genes, proteins, and methods of use thereof
12/01/2011	US20110293651 HPV E6 protein T cell epitopes and uses thereof
12/01/2011	US20110293650 Influenza virus-like particles (vlps) comprising hemagglutinin
12/01/2011	US20110293649 In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles
12/01/2011	US20110293639 Ideotypically modulated pharmacoeffectors for selective cell treatment
12/01/2011	US20110293638 Method to produce an immunoglobulin preparation with improved yield
12/01/2011	US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011	US20110293621 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
12/01/2011	US20110293616 Antigen-presenting complex-binding compositions and uses thereof
12/01/2011	US20110293598 Method to produce an immunoglobulin preparation with improved yield
12/01/2011	US20110293596 Disease control with tick phospholipase a2
12/01/2011	US20110293595 Prophylactic and therapeutic treatment of Alzheimer's Disease, neuro-degenerative diseases, protein aggregation diseases, Parkinson's Disease and amyloid diseases, using phytic acid and phytate
12/01/2011	US20110293566 Diffocin and methods of use thereof
12/01/2011	US20110293565 Novel synthetic agonists of tlr9
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	US20110293563 1'substituted carba-nucleoside analogs for antiviral treatment
12/01/2011	US20110293561 Anti-kir combination treatments and methods
12/01/2011	US20110293558 Material properties of t cells and related methods and compositions
12/01/2011	US20110293557 Conjugates for the administration of biologically active compounds
12/01/2011	US20110293555 Tumor necrosis factor-alpha mutants
12/01/2011	US20110293544 High unsaponifiables and methods of using the same
12/01/2011	US20110293539 Film containing compositions
12/01/2011	US20110293535 Composition for buccal absorption of nicotine for the purpose of smoking cessation
12/01/2011	US20110293528 Enema preparations and their use
12/01/2011	US20110293522 Surface modification of polymers via surface active and reactive end groups
12/01/2011	US20110293521 Anti-viral compositions and methods for administration
12/01/2011	US20110293516 Compositions and methods of use of targeting peptides against placenta and adipose tissues
12/01/2011	US20110293513 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/01/2011	DE102010022602A1 Natural antibiotic and food supplements from plant active ingredients, to treat e.g. cancer, comprises pulverized dried extract comprising e.g. fresh harvested rosemary leaves and peeled garlic toes, where extract is crushed and evaporated
12/01/2011	CA2836175A1 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
12/01/2011	CA2800734A1 Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
12/01/2011	CA2800530A1 Inhibitors of hcv ns5a
12/01/2011	CA2800509A1 Inhibitors of hcv ns5a
12/01/2011	CA2800382A1 Tamarind seed polysaccharide for use in the treatment of microbial infections
12/01/2011	CA2800272A1 Removal of serine proteases by treatment with finely divided silicon dioxide
12/01/2011	CA2800021A1 Levoisovalerylspiramycin i, ii, iii and preparations, preparation methods and uses thereof
12/01/2011	CA2800019A1 Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
12/01/2011	CA2799572A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
12/01/2011	CA2799029A1 Process for the preparation of pleuromutilins
12/01/2011	CA2798739A1 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	CA2798493A1 Synthetic nanocarrier combination vaccines
11/2011
11/30/2011	EP2390270A1 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
11/30/2011	EP2390268A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
11/30/2011	EP2390257A1 2'-fluoronucleosides
11/30/2011	EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011	EP2389938A1 Antifungal medicinal compositions

1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 1798